Sequanta Technologies, a leading multi-omics research and clinical service provider based in Shanghai, has announced a partnership with DarkJade Sciences, a renowned organoid specialist based in Beijing. The collaboration aims to leverage the respective strengths of both companies to establish an organoid bank, with the first project focusing on glioma research and development.
Establishing an Organoid Bank and Glioma Project
The partnership between Sequanta Technologies and DarkJade Sciences marks a significant step in advancing organoid technology in China. By establishing an organoid bank, the two companies aim to create a valuable resource for researchers and clinicians, facilitating the study of various diseases, including glioma, a type of brain cancer. The first project under this collaboration will concentrate on glioma, highlighting the urgency and importance of this research area.
Leveraging Complementary Expertise
The collaboration will see Sequanta Technologies and DarkJade Sciences leveraging their respective expertise in multi-omics research and organoid technology. This synergy is expected to accelerate the development of new diagnostic tools, therapeutic strategies, and personalized medicine approaches for glioma patients.-Fineline Info & Tech
